Edition:
United Kingdom

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

74.18USD
19 Oct 2018
Change (% chg)

$-0.35 (-0.47%)
Prev Close
$74.53
Open
$74.43
Day's High
$75.62
Day's Low
$73.98
Volume
1,972,373
Avg. Vol
1,590,890
52-wk High
$83.87
52-wk Low
$60.15

Summary

Name Age Since Current Position

David Dorman

64 2011 Independent Chairman of the Board

Larry Merlo

62 2011 President, Chief Executive Officer, Director

Eva Boratto

52 2018 Chief Financial Officer, Executive Vice President

Kevin Hourican

2018 President of CVS Pharmacy

Derica Rice

53 2018 President - CVS Caremark

Jonathan Roberts

62 2017 Chief Operating Officer, Executive Vice President

Lisa Bisaccia

61 2016 Chief Human Resource Officer, Executive Vice President

Thomas Moriarty

54 2017 Executive Vice President, General Counsel, Chief Policy and External Affairs Officer

Troyen Brennan

63 2008 Executive Vice President, Chief Medical Officer

Fernando Aguirre

60 2018 Independent Director

Mark Bertolini

62 2018 Independent Director

Richard Bracken

65 2015 Independent Director

C. David Brown

66 2007 Independent Director

Alecia DeCoudreaux

63 2015 Independent Director

Nancy-Ann DeParle

61 2013 Independent Director

Roger Farah

65 2018 Independent Director

Anne Finucane

65 2011 Independent Director

Edward Ludwig

67 2018 Independent Director

Jean-Pierre Millon

67 2007 Independent Director

Mary Schapiro

63 2017 Independent Director

Richard Swift

73 2006 Independent Director

William Weldon

69 2013 Independent Director

Tony White

71 2011 Independent Director

Biographies

Name Description

David Dorman

Mr. David W. Dorman is Independent Chairman of the Board of CVS Caremark Corp. Mr. Dorman has been the Chairman of the Board of CVS Health Corporation since May 2011. He has also been a Founding Partner of Centerview Capital Technology Fund, a private investment firm, since July 2013. He also served as Lead Director of Motorola Solutions, Inc. (formerly Motorola, Inc.), a communications products company, until his retirement from that board in May 2015, and was Non-Executive Chairman of the Board of Motorola from May 2008 through May 2011. From October 2006 through April 2008, he was a Managing Director and Senior Advisor with Warburg Pincus LLC, a global private equity firm. From November 2005 until January 2006, Mr. Dorman served as President and a director of AT&T Inc., a telecommunications company (formerly known as SBC Communications). From November 2002 until November 2005, Mr. Dorman was Chairman of the Board and Chief Executive Officer of AT&T Corporation. Mr. Dorman is also a director of PayPal Holdings, Inc., a leading digital and mobile payments company, as well as Dell Technologies Inc., the world’s largest privately controlled technology company. He was also a director of SecureWorks Corp., an information security solutions provider and a subsidiary of Dell, from the time of SecureWorks’ IPO in April 2016 until he joined the board of Dell in September 2016. He was a director of Yum! Brands, Inc., a global quick service restaurant company, from 2005 until his retirement from that board in May 2017. B.S., Georgia Institute of Technology.

Larry Merlo

Mr. Larry J. Merlo is President, Chief Executive Officer, Director of the Company. Mr. Merlo has been Chief Executive Officer of CVS Health Corporation since March 2011 and President of CVS Health Corporation since May 2010. Mr. Merlo formerly served as Chief Operating Officer of CVS Health Corporation from May 2010 through March 2011 and was President of CVS Pharmacy from January 2007 through May 2010, and Executive Vice President – Stores from April 2000 to January 2007. B.S., Pharmacy, University of Pittsburgh.

Eva Boratto

Ms. Eva C. Boratto is Chief Financial Officer, Executive Vice President of the Company. She joined CVS Health in 2010 as Senior Vice President, PBM Finance. From 2013 to 2017, Ms. Boratto served as Senior Vice President – Controller and Chief Accounting Officer. Ms. Boratto has held her current position at CVS Health since March 2017.

Kevin Hourican

Mr. Kevin Hourican is President of CVS Pharmacy of the Company. Hourican has more than 20 years of experience in the retail industry and most recently served as Executive Vice President, Retail Pharmacy, CVS Pharmacy. During his tenure as leader of the chain's retail pharmacy business, he directly managed all aspects of our retail pharmacy business and partnered on key innovations including the Script Path prescription management system, the Rx Savings Finder, medication adherence programs and home delivery. Previously, Hourican served as Senior Vice President, Operations for the East division of CVS Pharmacy, overseeing nearly 5,000 stores and more than 110,000 colleagues in 21 states, the District of Columbia and Puerto Rico. Prior to joining CVS Health in 2012, Hourican served in executive leadership roles at Macy's and Sears Roebuck where he gained significant experience in omni channel operations and front store merchandising. He holds an undergraduate degree in Economics as well as a master's degree from Pennsylvania State University.

Derica Rice

Mr. Derica W. Rice has been appointed President - CVS Caremark of the Company effective on March 30, 2018. Rice brings to CVS Caremark nearly 30 years of experience as a health care executive with a strong track record of delivering results in leadership positions. Rice joins CVS Health from Eli Lilly and Company where he most recently served as executive vice president of global services and chief financial officer. During his 27-year career at Eli Lilly, Rice was a key player in helping to drive the company's innovation strategy and held numerous roles in finance and operations, including as chief financial officer forLilly Canada, general manager of Lilly's U.K. affiliate, executive director and chief financial officer of European operations, and as Eli Lilly's vice president and controller. Rice earned his master's degree in business administration from Indiana University and a bachelor's degree in electrical engineering from Kettering University.

Jonathan Roberts

Mr. Jonathan C. Roberts is Chief Operating Officer, Executive Vice President of the Company. He was Executive Vice President of CVS Health Corporation and Chief Operating Officer of CVS Caremark from October 2010 through August 2011; Executive Vice President, Rx Purchasing, Pricing and Network Relations of CVS Health Corporation from January 2009 through October 2010.

Lisa Bisaccia

Mrs. Lisa G. Bisaccia is a Chief Human Resource Officer, Executive Vice President of the Company. She served as Senior Vice President of CVS Health Corporation from January 2010 through February 2016; Vice President, Human Resources of CVS Pharmacy, Inc. from September 2004 through December 2009. Ms. Bisaccia is also a member of the Board of Directors of Aramark, a leading global provider of food, facilities and uniform services.

Thomas Moriarty

Mr. Thomas M. Moriarty is Executive Vice President, General Counsel, Chief Policy and External Affairs Officer of the Company. Previously Chief Strategy Officer from March 2014 through February 2017; General Counsel of Celgene Corporation, a global biopharmaceutical company, from May 2012 through September 2012; General Counsel and Corporate Secretary of Medco Health Solutions, Inc. (“Medco”), a pharmacy benefit management company, from March 2008 through April 2012; also President of Global Pharmaceutical Strategies of Medco from March 2011 through April 2012.

Troyen Brennan

Dr. Troyen A. Brennan M.D., is a Executive Vice President, Chief Medical Officer of the Company. He was Executive Vice President and Chief Medical Officer of Aetna, Inc. from February 2006 through November 2008.

Fernando Aguirre

Mr. Fernando G. Aguirre is Independent Director of the Company. He has been a director at Aetna since 2011. Mr. Aguirre served as President and Chief Executive Officer from January 2004 to October 2012 and Chairman from May 2004 to October 2012 of Chiquita Brands International, Inc. (global distributor of consumer products). Prior to joining Chiquita, Mr. Aguirre worked for more than 23 years in brand management, general management and turnarounds at The Procter & Gamble Company (“P&G”) (manufacturer and distributor of consumer products). Mr. Aguirre began his P&G career in 1980, serving in various capacities including President and General Manager of P&G Brazil, President of P&G Mexico, Vice President of P&G’s global snacks and US food products, and President of global feminine care. In July 2002, Mr. Aguirre was named President, special projects, reporting to P&G’s Chairman and Chief Executive Officer, working on strategy. He served as a director of Coveris (packaging) from 2014 to 2015, Levi Strauss (manufacturer of clothing) from 2010 until August 2014, and Coca-Cola Enterprises Inc. (manufacturer and distributor of consumer products) from 2005 to 2010. Mr. Aguirre also serves as a director on the board of directors of Barry Callebaut AG (manufacturer of high-quality chocolate and cocoa products).

Mark Bertolini

Mr. Mark T. Bertolini is Independent Director of the Company. He has been a director at Aetna since 2010 and is the Chairman and Chief Executive Officer of Aetna. He assumed the roles of Chairman of Aetna’s board of directors on April 8, 2011 and Chief Executive Officer of Aetna on November 29, 2010. From July 2007 to December 2014, he served as President, responsible for all of Aetna’s businesses and operations. Mr. Bertolini joined Aetna in 2003 as head of Aetna’s Specialty Products, and subsequently served as Executive Vice President and head of Aetna’s regional businesses. Before joining Aetna, Mr. Bertolini held executive positions at Cigna, NYLCare Health Plans, and SelectCare, Inc., where he was President and Chief Executive Officer. Mr. Bertolini also serves as a director of Verizon Communications, Inc. (communications, information and entertainment products and services), Massachusetts Mutual Life Insurance Company (insurance and investment products and services), the Fidelco Guide Dog Foundation, the Peterson Institute for International Economics, Thrive Global and the Mind & Life Institute.

Richard Bracken

Mr. Richard M. Bracken is Independent Director of CVS Health Corporation. Mr. Bracken is the former Chairman and Chief Executive Officer of HCA Holdings, Inc., one of the nation’s leading providers of health care services. At the time of Mr. Bracken’s retirement, HCA’s facilities included approximately 165 hospitals and 115 freestanding surgery centers in 20 states and England. Mr. Bracken served in a number of executive roles in his 33 year career at HCA, including President of HCA’s Pacific Division in 1995, Western Group President in 1997, Chief Operating Officer of HCA in July 2001, and President and Chief Operating Officer in January 2002. He was elected to the HCA Board of Directors in November 2002, became President and Chief Executive Officer in January 2009, and Chairman and Chief Executive Officer in December, 2009. He retired as CEO in December 2013, and as Chairman in December 2014. B.A., San Diego State University; M.H.A., Medical College of Virginia, Virginia Commonwealth University.

C. David Brown

Mr. C. David Brown II is Independent Director of CVS Caremark Corp. Mr. Brown has been Chairman of Broad and Cassel, a Florida law firm, since March 2000. From 1989 until March 2000, he was Managing Partner of the Orlando office of the firm. He is also the lead director of Rayonier Advanced Materials Inc. (RYAM), a leading specialty cellulose production company. Mr. Brown previously served on the board of directors and as lead director of Rayonier Inc., a real estate development and timberland management company, prior to the spin-off of RYAM in June 2014. He also served as a director of ITT Educational Services, Inc., a national provider of technology-oriented undergraduate and graduate degree programs, from April 2015 until September 2016. Mr. Brown also previously served on the board of Caremark Rx, Inc. from March 2001 until the closing of the merger transaction involving CVS Health and Caremark, when he became a director of CVS Health. B.S.B.A., University of Florida; J.D., University of Florida College of Law.

Alecia DeCoudreaux

Ms. Alecia A. DeCoudreaux. JD., is an Independent Director of Company. Ms. DeCoudreaux is the former President of Mills College, a liberal arts college for women with graduate programs for women and men, having served a five-year term in that position from July 2011 through June 2016. Previously, Ms. DeCoudreaux served in a number of leadership roles at Eli Lilly and Company, a global pharmaceutical manufacturer, including as Vice President and Deputy General Counsel, Specialty Legal Team, from 2010-2011, Vice President and General Counsel, Lilly USA, from 2005-2009, and Secretary and Deputy General Counsel of Eli Lilly from 1999-2005. During her 30-year career with Eli Lilly Ms. DeCoudreaux also previously served as Executive Director of Lilly Research Laboratories, Director of Federal Government Relations, Director of State Government Relations and Director of Community Relations. In addition, Ms. DeCoudreaux has served on a number of charitable, educational, for profit and nonprofit boards, including as both a trustee and board chair at Wellesley College. B.A., Wellesley College; J.D., Indiana University School of Law.

Nancy-Ann DeParle

Ms. Nancy-Ann M. DeParle serves as Independent Director of CVS Caremark Corporation, Ms. DeParle has been a Co-Founding Partner of Consonance Capital Partners, LLC, a private equity firm focused on investing in small and mid-size health care companies, since August 2013. From March 2009 to January 2013, Ms. DeParle served in the White House, first as Counselor to the President and Director of the White House Office of Health Reform, and later as Assistant to the President and Deputy Chief of Staff for Policy. In addition, from 1993 to 2000, Ms. DeParle served as the Associate Director for Health and Personnel for the White House Office of Management and Budget, and later as the Administrator of the Centers for Medicare and Medicaid Services (then known as the Health Care Financing Administration). From 2001 to March 2009, Ms. DeParle served as a Senior Advisor with JPMorgan Partners and as a Managing Director of its successor entity, CCMP Capital, L.L.C., focusing on private equity investments in health care companies. Ms. DeParle is also a director of HCA Holdings, Inc., a health care services company that owns, manages or operates hospitals and various other health care facilities. B.A., University of Tennessee; B.A. and M.A., Balliol College, Oxford University; J.D., Harvard Law School.

Roger Farah

Mr. Roger N. Farah is Independent Director of the Company. He has been a director at Aetna since 2007 and Chairman of the Board and a director of Tiffany & Co. (jewelry and specialty products). He served as Executive Director of Tory Burch LLC (lifestyle products) from March 2017 to September 2017, having previously served as Co-Chief Executive Officer and Director from September 2014 to February 2017. He is former Executive Vice Chairman of Ralph Lauren Corporation (lifestyle products) having served in that position from November 2013 to May 2014, and previously served as President and Chief Operating Officer from April 2000 to October 2013, and Director from April 2000 to August 2014. Earlier, Mr. Farah served as Chairman of the Board of Venator Group, Inc. (now Foot Locker, Inc.) from December 1994 to April 2000, and as its Chief Executive Officer from December 1994 to August 1999. Mr. Farah served as President and Chief Operating Officer of R.H. Macy & Co., Inc. from July 1994 to October 1994. From June 1991 to July 1994, he was Chairman and Chief Executive Officer of Federated Merchandising Services (retailing), the central buying and product development arm of Federated Department Stores, Inc. (retailing). From 1988 to 1991, Mr. Farah served as Chairman and Chief Executive Officer of Rich’s/Goldsmith’s Department Stores (retailing) and previously as its President from 1987 to 1988. He held a number of positions of increasing responsibility at Saks Fifth Avenue, Inc. (retailing) from 1975 to 1987. Mr. Farah also serves as a director on the board of directors of The Progressive Corporation (auto insurance), and Metro Bank PLC (financial services).

Anne Finucane

Ms. Anne M. Finucane is Independent Director of Cvs Caremark Corp. Ms. Finucane has been Vice Chairman of Bank of America Corporation, an international financial services company, since July 2015 and is a member of its executive management team. From 2006 through July 2015 Ms. Finucane served as Global Chief Strategy and Marketing Officer for Bank of America and served as Northeast Market President from 2004 through July 2015. During her twenty-plus years as a senior leader at Bank of America and its legacy firms, Ms. Finucane has served as senior advisor to four chief executive officers and the Board of Directors. Ms. Finucane is responsible for the strategic positioning of Bank of America and oversees the public policy, customer research and analytics, global marketing, communications and corporate social responsibility efforts for the company. She is chair of Bank of America’s Environmental, Social and Governance Committee, and is also chair of the Bank of America Charitable Foundation. B.A., University of New Hampshire.

Edward Ludwig

Mr. Edward J. Ludwig is Independent Director of the Company. He is the lead director of Aetna’s board of directors and has been a director at Aetna since 2003. He is the former Chairman of the board of directors of Becton, Dickinson and Company (“BD”) (global medical technology company), having served in this position from February 2002 through June 2012. He also served as Chief Executive Officer of BD from January 2000 to September 2011, President of BD from May 1999 to December 2008, and Chief Financial Officer of BD from January 1995 to May 1999. Mr. Ludwig joined BD as a Senior Financial Analyst in 1979. Prior to joining BD, Mr. Ludwig was a senior auditor with Coopers and Lybrand (now PricewaterhouseCoopers) where he earned his CPA, and served as a financial and strategic analyst at Kidde, Inc. Mr. Ludwig also served as Director of Xylem, Inc. (water technology company) from 2011 to 2017, and Chairman of Advanced Medical Technology Association, or AdvaMed, (medical device trade association) from 2006 to 2008. He serves as the lead independent director on the board of directors of Boston Scientific Corporation (medical devices) and as a director of POCARED Diagnostics Ltd. (diagnostics technology manufacturer).

Jean-Pierre Millon

Mr. Jean-Pierre Millon is Independent Director of CVS Caremark Corp. Mr. Millon is the retired former President and Chief Executive Officer of PCS Health Systems, Inc. Mr. Millon joined PCS in 1995, where he served as President and Chief Executive Officer from June 1996 until his retirement in September 2000. Prior to that, Mr. Millon served as an executive and held several global leadership positions with Eli Lilly and Company. Mr. Millon previously served on the board of Caremark from March 2004, upon Caremark’s acquisition of AdvancePCS, and as a director of AdvancePCS (which resulted from the merger of PCS and Advance Paradigm, Inc.) beginning in October 2000. He became a director of CVS Health upon the closing of the merger transaction involving CVS Health and Caremark. Mr. Millon has over 10 years of financial management experience and fifteen years of general functional management experience, including strategic planning experience specific to pharmacy benefit management companies as the former head of PCS. He also has extensive venture capital and public and private company board experience. B.S., Ecole Centrale de Lyon (France); B.A., Université de Lyon (France); M.B.A., Kellogg School of Business, Northwestern University.

Mary Schapiro

Ms. Mary L. Schapiro is Independent Director of the Company. Since January 2014, Ms. Schapiro has served as the Vice Chair of Promontory Advisory Board, part of Promontory Financial Group, a leading strategy, risk management and regulatory compliance firm that was acquired by IBM Corporation in November 2016. She previously served as managing director of Promontory Financial Group from March 2013 through January 2014. From January 2009 through December 2012, Ms. Schapiro was Chairman of the U.S. Securities and Exchange Commission, becoming the first woman to serve as that agency’s Chairman. Prior to becoming SEC Chairman, Ms. Schapiro was Chairman and CEO of the Financial Industry Regulatory Authority (FINRA) from 2006 through 2008, and prior to that held a number of key executive positions at FINRA and its predecessor from 1996 through 2006, including Vice Chairman and President of NASD Regulation. She also served as Chairman of the Commodity Futures Trading Commission (CFTC) from 1994 to 1996, and was the only person to serve as Chairman of both the CFTC and the SEC. Ms. Schapiro is also a director of The London Stock Exchange Group plc, which engages in market infrastructure and the capital markets business. Ms. Schapiro was also a director of General Electric Company (GE), a global diversified infrastructure company, from April 2013 until her retirement from that board effective at the time of GE’s April 2018 annual meeting. B.A., Franklin and Marshall College; J.D., George Washington University.

Richard Swift

Mr. Richard J. Swift is Independent Director of CVS Caremark Corp. Mr. Swift is the former Chairman of the Board, President and Chief Executive Officer of Foster Wheeler Ltd., an international engineering and construction firm, having served in those positions from April 1994 until his retirement in October 2001. Mr. Swift also served as a member and as Chairman of the Financial Accounting Standards Advisory Council (FASAC) from 2002 until his retirement from FASAC in December 2006. Mr. Swift is also lead director of Ingersoll-Rand plc, a diversified industrial company, and a director of Kaman Corporation, a diversified manufacturer and distributor, Hubbell Incorporated, an electrical and electronic products company, and Public Service Enterprise Group Incorporated, an energy company. B.S., U.S. Military Academy at West Point; M.S., Purdue University; M.B.A., Fairleigh Dickinson University.

William Weldon

Mr. William C. Weldon is an Independent Director of CVS Caremark Corp. Mr. Weldon is the former Chairman of the Board and Chief Executive Officer of Johnson & Johnson, a global developer and manufacturer of health care products, having served in those positions from 2002 until his retirement as Chief Executive Officer in April 2012 and his retirement from the board in December 2012. Mr. Weldon previously served in a variety of senior executive positions during his 41-year career with Johnson & Johnson. Mr. Weldon is also a director of JPMorgan Chase & Co., a global financial services company, and Exxon Mobil Corporation, an international oil and gas company. He was formerly a director of The Chubb Corporation, an international insurance company, until it was acquired by ACE Limited in January 2016. B.S., Quinnipiac University.

Tony White

Mr. Tony Lee White is Independent Director of Cvs Caremark Corp. Mr. White is the former Chairman of the Board, President and Chief Executive Officer of Applied Biosystems, Inc. (formerly Applera Corporation), a developer, manufacturer and marketer of life science systems and genomic information products, having served in those positions from September 1995 until his retirement in November 2008. Mr. White is also a director of Ingersoll-Rand plc, a diversified industrial company. He was a director of C.R. Bard, Inc. (Bard), a company that designs, manufactures and sells medical, surgical, diagnostic and patient care devices, from 1996 until Bard was acquired by Becton Dickinson and Company in December 2017. B.A., Western Carolina University.